ATE402260T1 - Rekombinante lactoferrin, verfahren zu ihrer herstellung mittels pflanzen und ihre verwendung - Google Patents

Rekombinante lactoferrin, verfahren zu ihrer herstellung mittels pflanzen und ihre verwendung

Info

Publication number
ATE402260T1
ATE402260T1 AT98924373T AT98924373T ATE402260T1 AT E402260 T1 ATE402260 T1 AT E402260T1 AT 98924373 T AT98924373 T AT 98924373T AT 98924373 T AT98924373 T AT 98924373T AT E402260 T1 ATE402260 T1 AT E402260T1
Authority
AT
Austria
Prior art keywords
lactoferrin
derived proteins
plants
production
plant cell
Prior art date
Application number
AT98924373T
Other languages
English (en)
Inventor
Dominique Legrand
Valerie Salmon
Genevieve Spik
Veronique Gruber
Philippe Bournat
Bertrand Merot
Original Assignee
Meristem Therapeutics S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meristem Therapeutics S A filed Critical Meristem Therapeutics S A
Application granted granted Critical
Publication of ATE402260T1 publication Critical patent/ATE402260T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT98924373T 1997-05-02 1998-05-04 Rekombinante lactoferrin, verfahren zu ihrer herstellung mittels pflanzen und ihre verwendung ATE402260T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9705699A FR2762850B1 (fr) 1997-05-02 1997-05-02 Lactoferrines recombinantes, leurs procedes de production par les plantes ainsi que leurs utilisations

Publications (1)

Publication Number Publication Date
ATE402260T1 true ATE402260T1 (de) 2008-08-15

Family

ID=9506722

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98924373T ATE402260T1 (de) 1997-05-02 1998-05-04 Rekombinante lactoferrin, verfahren zu ihrer herstellung mittels pflanzen und ihre verwendung

Country Status (9)

Country Link
US (3) US6569831B1 (de)
EP (1) EP0981617B1 (de)
JP (1) JP2001527406A (de)
AT (1) ATE402260T1 (de)
AU (1) AU7659298A (de)
CA (1) CA2288435A1 (de)
DE (1) DE69839768D1 (de)
FR (1) FR2762850B1 (de)
WO (1) WO1998050543A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2762850B1 (fr) * 1997-05-02 2000-02-11 Biocem Lactoferrines recombinantes, leurs procedes de production par les plantes ainsi que leurs utilisations
IT1299565B1 (it) * 1998-07-17 2000-03-16 Plantechno S R L Polinucleotide sintetico codificante per la lattoferrina umana, vettori, cellule e piante transgeniche che lo contengono.
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
EP1163352A1 (de) * 1999-03-17 2001-12-19 University Of Victoria Innovation And Development Corporation Transgene pflanzen die gegen ein breites spektrum von pathogenen resistent sind
US6835868B1 (en) 1999-03-17 2004-12-28 University Of Victoria Innovation And Development Corporation Transgenic plants expressing dermaseptin peptides providing broad spectrum resistance to pathogens
US6991824B2 (en) * 2000-05-02 2006-01-31 Ventria Bioscience Expression of human milk proteins in transgenic plants
US7304208B2 (en) 2000-05-02 2007-12-04 Ventria Bioscience Expression of human serum albumin (HSA) in monocot seeds
US7417178B2 (en) * 2000-05-02 2008-08-26 Ventria Bioscience Expression of human milk proteins in transgenic plants
US7138150B2 (en) * 2000-05-02 2006-11-21 Ventria Bioscience Method of making an anti-infective composition for treating oral infections
WO2001083792A2 (en) 2000-05-02 2001-11-08 Applied Phytologics, Inc. Enhanced gene expression in plants using transcription factors
US20080050503A1 (en) * 2000-05-02 2008-02-28 Ning Huang Expression of human milk proteins in transgenic plants
AU2012202697B2 (en) * 2001-02-14 2015-05-07 Ventria Bioscience Expression of human milk proteins in transgenic plants
JP2004528022A (ja) * 2001-02-14 2004-09-16 ベントリア バイオサイエンス トランスジェニック植物におけるヒト乳タンパク質の発現
CA2437819A1 (en) * 2001-02-14 2002-08-22 Ventria Bioscience Feed additive compositions and methods
ES2467155T3 (es) * 2001-02-14 2014-06-12 Ventria Bioscience Expresión de proteínas de leche humana en plantas transgénicas
SE0200598D0 (sv) * 2002-02-27 2002-02-27 A & Science Invest Ab Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
WO2004060392A1 (en) * 2002-12-20 2004-07-22 Ventria Bioscience Lactoferrin protein with iron for treating iron deficiency and anemia
JP2007517504A (ja) * 2003-12-09 2007-07-05 ベントリア バイオサイエンス 融合担体として種子貯蔵蛋白を利用する植物種子中の融合ポリペプチドの高水準発現
US20080010697A1 (en) * 2003-12-23 2008-01-10 Daichang Yang Methods of Expressing Heterologous Protein in Plant Seeds Using Monocot Non Seed-Storage Protein Promoters
KR20080039885A (ko) * 2005-06-28 2008-05-07 벤트리아 바이오사이언스 식물 세포로부터 생산된 세포 배양 배지의 성분
KR20080038131A (ko) 2005-07-18 2008-05-02 프로탈릭스 리미티드 생물학적으로 활성인 거대분자의 점막 또는 장관 투여
WO2007038623A2 (en) * 2005-09-28 2007-04-05 Ventria Bioscience Oral formulation for enteric disorders and/or rehydration
EP1808491A1 (de) * 2006-01-13 2007-07-18 Meristem Therapeutics S.A. Genetisch modifizierte Pflanze mit verändertem Gehalt an Reserveproteinen
NZ555163A (en) 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
SG173469A1 (en) 2009-02-20 2011-09-29 Ventria Bioscience Cell culture media containing combinations of proteins
WO2020096672A1 (en) 2018-11-09 2020-05-14 The Wistar Institute Of Anatomy And Biology Use of lactoferrin for generating myeloid-derived suppressor cells
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants
WO2022072718A1 (en) 2020-09-30 2022-04-07 Nobell Foods, Inc. Recombinant milk proteins and food compositions comprising the same
CN118324930B (zh) * 2024-06-13 2024-08-20 广州暨南大学医药生物技术研究开发中心有限公司 重组人源化乳铁蛋白及其制备方法
CN120271696B (zh) * 2025-06-11 2025-08-19 杭州纽龙生物科技有限公司 一种基于大肠杆菌载体的重组人乳铁蛋白的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030339A1 (en) * 1994-05-05 1995-11-16 Ferrodynamics, Inc. Cloning, expression, and uses of human lactoferrin
KR0154495B1 (ko) * 1995-05-22 1998-10-15 김은영 인체 락토페린 유전자로 형질전환된 항바이러스성 식물체의 제조방법
FR2736930B1 (fr) 1995-07-17 1997-09-19 Biocem Procede de production, par des cellules vegetales, de proteines heminiques, proteines ainsi obtenues et produits contenant ces proteines
WO1998006860A1 (en) 1996-08-14 1998-02-19 Novartis Ag Peptide with inhibitory activity towards plant pathogenic fungi
FR2762850B1 (fr) * 1997-05-02 2000-02-11 Biocem Lactoferrines recombinantes, leurs procedes de production par les plantes ainsi que leurs utilisations

Also Published As

Publication number Publication date
US20030229925A1 (en) 2003-12-11
WO1998050543A1 (fr) 1998-11-12
FR2762850B1 (fr) 2000-02-11
US20110092411A1 (en) 2011-04-21
EP0981617B1 (de) 2008-07-23
JP2001527406A (ja) 2001-12-25
US7354902B2 (en) 2008-04-08
EP0981617A1 (de) 2000-03-01
AU7659298A (en) 1998-11-27
US8334254B2 (en) 2012-12-18
CA2288435A1 (fr) 1998-11-12
US6569831B1 (en) 2003-05-27
FR2762850A1 (fr) 1998-11-06
DE69839768D1 (de) 2008-09-04

Similar Documents

Publication Publication Date Title
DE69839768D1 (de) Rekombinante lactoferrin, verfahren zu ihrer herstellung mittels pflanzen und ihre verwendung
ATE308614T1 (de) Durch pflanzen hergestelltes rekombinantes kollagen, verfahren zu ihrer herstellung und verwendung
ATE339509T1 (de) Stress-gekoppelter transkriptionsfaktor und dessen verwendung in pflanzen
ATE286126T1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
ATE252157T1 (de) Nucleinsäuremoleküle aus pflanzen codierend enzyme, die an der stärkesynthese beteiligt sind
DE69737507D1 (de) Neue nukleinsäuremoleküle aus mais und deren verwendung zur herstellung modifizierter stärke
ATE447855T1 (de) Verfahren zur herstellung einer modifizierten stärke
ATE248872T1 (de) Alkoxysilan-endgruppen aufweisende polyurethanprepolymere, ein verfahren zu ihrer herstellung sowie ihre verwendung zur herstellung von dichtstoffen
DE69030539D1 (de) Wachstumsfaktor aus parenchymalen Lebenszellen, dafür kodierendes Gen, Verfahren zur Herstellung dieses Faktors und Transformanten
DE59003144D1 (de) Destillationsanlage zur Herstellung von Wasserstoff-Peroxid.
DE3787998D1 (de) ART-Nukleotidsegmente, -Vektoren, -Zellinien, Verfahren zur Herstellung und Verwendung.
DE68907608D1 (de) Verfahren zur herstellung von lignin-peroxidase durch verwendung von nichtproliferierenden phanerochaete chryosporium-zellen.
DE69332148D1 (de) Verwendung einer dna sequenz, kodierende für ein protein mit der fäligkeit oxalsäure abzubauen, zur genselektion
DE59404358D1 (de) Verfahren zur herstellung von 1,4-butandiol
DE69634753D1 (de) "targeting" polypeptide der inneren plastidenhüllmembran; ihre herstellung und verwendung
DE50010015D1 (de) Tetrahydropyrimidin-dioxygenase-gen, dadurch kodierte polypeptide und verfahren zur deren herstellung
ATE77621T1 (de) 3-perfluoroalkyl-isoxazol-5-yl-oxycarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als herbizide.
ATE364082T1 (de) Verfahren zur herstellung von pflanzen mit erhöhter resistenz gegen wasserstress
DE3768985D1 (de) Verwendung eines feststoffkatalysators zur herstellung von chlorfluorkohlenwasserstoffen.
ATE359364T1 (de) Verfahren zur mutagenese von nukleotidsequenzen aus pflanzen, algen, oder pilzen
ATE91502T1 (de) Verfahren zur herstellung von lignin-peroxidase durch verwendung von nichtproliferierenden phanerochaete chryosporium-zellen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties